NASDAQ, LXRX - Lexicon Pharmaceutcl
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
discovery and development of breakthrough treatments for human disease. We use
our proprietary gene knockout technology to knock out, or disrupt, the function
of genes in mice and then employ an integrated platform of advanced medical
technologies to systematically discover the physiological and behavioral
functions of the genes we have knocked out and assess the utility of the
proteins encoded by the corresponding human genes as potential drug targets. For
targets that we believe have high pharmaceutical value, we engage in programs
for the discovery and development of potential small molecule, antibody and
protein drugs. We have advanced four drug candidates into human clinical trials,
with one additional drug candidate in preclinical development and compounds from
a number of additional programs in various stages of preclinical research. ...
Read SEC Filing on NASDAQ.com »